Daniel J. Brennan Boston Scientific Corp (BSX) insider trading activity

Daniel J. Brennan is EVP and CFO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 223,921 shares of BSX, which is worth approximately $20.4 Million. The most recent transaction as insider was on Jan 01, 2022, when has been sold 13,193 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K

0% 3M change

0.9% 12M change

Total Value Held $20.4 Million

Daniel J. Brennan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2022	BUY Exercise of conversion of derivative security	-	13,193 Added 4.56%	276,436 Common Stock
Mar 03 2021	SELL Open market or private sale	$469,194 $38.69 p/Share	12,127 Reduced 4.4%	263,243 Common Stock
Mar 02 2021	SELL Open market or private sale	$368,009 $38.84 p/Share	9,475 Reduced 3.33%	275,370 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$77,095 $38.78 p/Share	1,988 Reduced 0.69%	284,845 Common Stock
Feb 28 2021	BUY Exercise of conversion of derivative security	-	4,481 Added 1.54%	286,833 Common Stock
Feb 23 2021	SELL Open market or private sale	$974,709 $39.23 p/Share	24,846 Reduced 8.09%	282,352 Common Stock
Feb 23 2021	BUY Exercise of conversion of derivative security	$177,897 $7.16 p/Share	24,846 Added 7.48%	307,198 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$100,744 $39.2 p/Share	2,570 Reduced 0.9%	282,352 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	5,794 Added 1.99%	284,922 Common Stock
Feb 21 2021	SELL Payment of exercise price or tax liability	$61,761 $38.03 p/Share	1,624 Reduced 0.58%	279,128 Common Stock
Feb 21 2021	BUY Exercise of conversion of derivative security	-	3,661 Added 1.29%	280,752 Common Stock
Feb 18 2021	SELL Payment of exercise price or tax liability	$61,683 $37.52 p/Share	1,644 Reduced 0.59%	277,091 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	-	3,706 Added 1.31%	278,735 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$70,714 $38.39 p/Share	1,842 Reduced 0.67%	275,029 Common Stock
Feb 15 2021	BUY Exercise of conversion of derivative security	-	4,153 Added 1.48%	276,871 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$261,072 $38.85 p/Share	6,720 Reduced 2.4%	272,718 Common Stock
Feb 10 2021	BUY Grant, award, or other acquisition	-	16,195 Added 5.48%	279,438 Common Stock
Jan 05 2021	SELL Open market or private sale	$603,372 $35.32 p/Share	17,083 Reduced 6.09%	263,243 Common Stock
Jan 01 2021	SELL Payment of exercise price or tax liability	$265,886 $35.95 p/Share	7,396 Reduced 2.57%	280,326 Common Stock
Jan 01 2021	BUY Exercise of conversion of derivative security	-	24,479 Added 7.84%	287,722 Common Stock

Also insider at

NUAN

Nuance Communications, Inc. Technology

Director

WAT

WATERS CORP Healthcare

Director

DJB

Daniel J. Brennan

EVP and CFO

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account